Findings from Denosumab (Prolia (R)) Post-marketing Safety Surveillance for Atypical Femoral Fracture, Osteonecrosis of the Jaw, Severe Symptomatic Hypocalcemia, and Anaphylaxis
Year: 2014
Type: article
Authors: Geller, M., Wagman, R.B., Ho, P.R., Siddhanti, S., Stehman-Breen, C., Watts, N.B., Papapoulos, S.
Language: English
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3208418247